RECESSIVE DYSTROPHIC EPIDERMOLYSIS BULLOSA
Clinical trials for RECESSIVE DYSTROPHIC EPIDERMOLYSIS BULLOSA explained in plain language.
Never miss a new study
Get alerted when new RECESSIVE DYSTROPHIC EPIDERMOLYSIS BULLOSA trials appear
Sign up with your email to follow new studies for RECESSIVE DYSTROPHIC EPIDERMOLYSIS BULLOSA, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
By submitting, you agree to our Terms of use
-
New combo therapy aims to heal fragile skin
Disease control Recruiting nowThis study is testing if adding an IV immunoglobulin (IV IgG) treatment to an existing gene therapy (VYJUVEK) helps wounds heal better in people with Recessive Dystrophic Epidermolysis Bullosa (RDEB), a severe genetic skin condition. The main goal is to see if this combination re…
Matched conditions: RECESSIVE DYSTROPHIC EPIDERMOLYSIS BULLOSA
Phase: PHASE1, PHASE2 • Sponsor: M. Peter Marinkovich • Aim: Disease control
Last updated Apr 01, 2026 14:42 UTC
-
New eye drop aims to soothe painful scratches in rare skin disorder
Disease control Recruiting nowThis study is testing whether an investigational eye drop called KB803 can safely reduce the frequency and pain of corneal abrasions (scratches on the eye's surface) in people with dystrophic epidermolysis bullosa (DEB), a rare genetic skin condition. Participants, including chil…
Matched conditions: RECESSIVE DYSTROPHIC EPIDERMOLYSIS BULLOSA
Phase: PHASE3 • Sponsor: Krystal Biotech, Inc. • Aim: Disease control
Last updated Apr 01, 2026 14:41 UTC
-
Scientists grow 'Permanent' Gene-Fixed skin to heal devastating wounds
Disease control Recruiting nowThis study is testing a new, lab-grown skin graft for people with Recessive Dystrophic Epidermolysis Bullosa (RDEB), a painful genetic condition that causes fragile, blistering skin. The graft is made from a patient's own skin cells, which are genetically corrected in a lab to pr…
Matched conditions: RECESSIVE DYSTROPHIC EPIDERMOLYSIS BULLOSA
Phase: PHASE1, PHASE2 • Sponsor: CHU de Quebec-Universite Laval • Aim: Disease control
Last updated Apr 01, 2026 14:41 UTC